M
Mach5 Therapeutics
Biotechnology firm advancing therapeutics for immune-mediated inflammatory and fibrotic diseases
About Mach5 Therapeutics
Mach5 Therapeutics is a privately held biotechnology company focused on developing advanced therapeutics for immune-mediated inflammatory and fibrotic diseases. Founded by experienced drug developers from ValenzaBio and AlmataBio, the company aims to transform patient care through its innovative approach to medicine. Operating in the biotechnology sector, Mach5 Therapeutics targets healthcare providers and patients affected by these complex conditions. The business model revolves around research and development, with revenue generated through partnerships, licensing agreements, and potential commercialization of successful therapies. The company's strategic focus is on leveraging its expertise to address unmet medical needs in the field of immunology and fibrosis.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2023
- Headquarters
- Atlanta, United States
- Employees
- 1
- Open positions
- None listed
- Dealroom signal
- 56.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Woman Founder, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2024 | $19M | $77M | Undisclosed | ↗ |
| SEED✓Equity / VC | Mar 2024 | $4.2M | $17M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Mach5 Therapeutics is 1.5K monthly website visits, up 70.5% over the last three months. Mach5 Therapeutics's team declined 50% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Mach5 Therapeutics in the Atlanta ecosystem
The Mach5 Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mach5 Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mach5 Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









